National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, 113 Thailand Science Park, Pathumthani 12120, Thailand.
Anal Biochem. 2012 Feb 1;421(1):26-36. doi: 10.1016/j.ab.2011.10.005. Epub 2011 Oct 6.
Antibodies are very important materials for diagnostics. A rapid and simple hybridoma screening method will help in delivering specific monoclonal antibodies. In this study, we systematically developed the first antibody array to screen for bacteria-specific monoclonal antibodies using Listeria monocytogenes as a bacteria model. The antibody array was developed to expedite the hybridoma screening process by printing hybridoma supernatants on a glass slide coated with an antigen of interest. This screening method is based on the binding ability of supernatants to the coated antigen. The bound supernatants were detected by a fluorescently labeled anti-mouse immunoglobulin. Conditions (slide types, coating, spotting, and blocking buffers) for antibody array construction were optimized. To demonstrate its usefulness, antibody array was used to screen a sample set of 96 hybridoma supernatants in comparison to ELISA. Most of the positive results identified by ELISA and antibody array methods were in agreement except for those with low signals that were undetectable by antibody array. Hybridoma supernatants were further characterized with surface plasmon resonance to obtain additional data on the characteristics of each selected clone. While the antibody array was slightly less sensitive than ELISA, a much faster and lower cost procedure to screen clones against multiple antigens has been demonstrated.
抗体是诊断学中非常重要的材料。一种快速而简单的杂交瘤筛选方法将有助于提供特异性的单克隆抗体。在这项研究中,我们系统地开发了第一个抗体阵列,以李斯特菌作为细菌模型,筛选针对细菌的单克隆抗体。抗体阵列通过将杂交瘤上清液打印在涂有感兴趣抗原的载玻片上,加速了杂交瘤的筛选过程。这种筛选方法基于上清液与涂层抗原的结合能力。用荧光标记的抗小鼠免疫球蛋白检测结合的上清液。优化了抗体阵列构建的条件(载玻片类型、涂层、点样和封闭缓冲液)。为了证明其有用性,我们将抗体阵列用于筛选一组 96 个杂交瘤上清液,与 ELISA 进行比较。ELISA 和抗体阵列方法鉴定的大多数阳性结果是一致的,除了那些信号较弱、抗体阵列无法检测到的结果。我们进一步用表面等离子体共振对杂交瘤上清液进行了表征,以获得每个选定克隆特征的更多数据。虽然抗体阵列的灵敏度略低于 ELISA,但已经证明了一种针对多种抗原进行克隆筛选的更快、成本更低的方法。